Cullinan Therapeutics (CGEM) Insider Trading & Ownership → The only AI company to buy (From Porter & Company) (Ad) Free CGEM Stock Alerts $22.68 -0.35 (-1.52%) (As of 05/29/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cullinan Therapeutics (NASDAQ:CGEM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.07%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.34 M Get CGEM Insider Trade Alerts Want to know when executives and insiders are buying or selling Cullinan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CGEM Insider Buying and Selling by Quarter Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Cullinan Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/6/2024Jennifer MichaelsonInsiderSell58,000$28.07$1,628,060.00 2/1/2024Corrine SavillInsiderSell40,000$16.18$647,200.00 1/29/2024Corrine SavillInsiderSell40,000$14.09$563,600.00 1/22/2024Corrine SavillInsiderSell18,684$12.14$226,823.76 12/26/2023Nadim AhmedCEOSell4,272$9.24$39,473.28 12/21/2023Jeffrey Alan JonesInsiderSell1,860$8.50$15,810.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/21/2023Jeffrey TrigilioCFOSell1,920$8.50$16,320.00 12/18/2023Jeffrey Alan JonesInsiderSell386$8.22$3,172.92 12/18/2023Jeffrey TrigilioCFOSell398$8.22$3,271.56 12/12/2023Jeffrey TrigilioCFOSell1,926$7.81$15,042.06 12/12/2023Jennifer MichaelsonInsiderSell1,068$7.81$8,341.08 6/28/2023Nadim AhmedCEOSell759$11.40$8,652.60 6/20/2023Jeffrey Alan JonesInsiderSell387$12.94$5,007.78 6/20/2023Jeffrey TrigilioCFOSell399$12.94$5,163.06 6/12/2023Jeffrey TrigilioCFOSell319$13.11$4,182.09 6/12/2023Jennifer MichaelsonInsiderSell176$13.11$2,307.36 6/6/2023Jennifer MichaelsonInsiderSell11,900$12.31$146,489.00 (Data available from 1/1/2013 forward) CGEM Insider Trading Activity - Frequently Asked Questions Who is on Cullinan Therapeutics's Insider Roster? The list of insiders at Cullinan Therapeutics includes Ansbert Gadicke, Bioscience I 2017 Ltd F2, Bvf Partners L P/Il, Corrine Savill, Jeffrey Alan Jones, Jeffrey Trigilio, Jennifer Michaelson, Leigh Zawel, Nadim Ahmed, Oncology Impact Fund L.P. Ubs, and Vision Scs F2. Learn more on insiders at CGEM. What percentage of Cullinan Therapeutics stock is owned by insiders? 6.07% of Cullinan Therapeutics stock is owned by insiders. Learn more on CGEM's insider holdings. Which Cullinan Therapeutics insiders have been buying company stock? The following insiders have purchased CGEM shares in the last 24 months: Bvf Partners L P/Il ($8,265,356.00), and Nadim Ahmed ($100,316.00). How much insider buying is happening at Cullinan Therapeutics? Insiders have purchased a total of 759,486 CGEM shares in the last 24 months for a total of $8,365,672.00 bought. Which Cullinan Therapeutics insiders have been selling company stock? The following insiders have sold CGEM shares in the last 24 months: Bioscience I 2017 Ltd F2 ($670,216.63), Corrine Savill ($2,046,756.28), Jeffrey Alan Jones ($32,603.82), Jeffrey Trigilio ($62,549.89), Jennifer Michaelson ($2,009,664.34), Nadim Ahmed ($69,597.43), and Vision Scs F2 ($439,469.79). How much insider selling is happening at Cullinan Therapeutics? Insiders have sold a total of 331,607 Cullinan Therapeutics shares in the last 24 months for a total of $5,330,858.18 sold. More Insider Trading Tools from MarketBeat Related Companies: Relay Therapeutics Insider Transactions Scholar Rock Insider Transactions Prime Medicine Insider Transactions ProKidney Insider Transactions Humacyte Insider Transactions CARGO Therapeutics Insider Transactions REGENXBIO Insider Transactions HilleVax Insider Transactions 4D Molecular Therapeutics Insider Transactions BioCryst Pharmaceuticals Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:CGEM) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe #1 Crypto for AIWeiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
